Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine
About this episode
Plus: Target’s second-quarter sales suggest the retailer’s turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi’s prediction markets. Alex Ossola hosts.
Sign up for WSJ’s free What’s News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time WSJ Minute Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WSJ Minute Briefing
U.S. Stocks Fall for Third Straight Session
WSJ Minute Briefing
Huawei’s Criminal Trial Kicks Off in New York City
WSJ Minute Briefing
Stocks Fall as Oil Tops $100
WSJ Minute Briefing
U.S. Stocks Fall as Oil Prices Climb Toward $100
WSJ Minute Briefing